Registered entities
Apellis Pharmaceuticals, Inc.
Reg. No. 214632499United States
APELLIS PHARMACEUTICALS, INC.
Reg. No. 1492422United States
Apellis Pharmaceuticals, Inc.
Reg. No. 20181328397United States
APELLIS PHARMACEUTICALS
Reg. No. 271537290United States
Apellis Pharmaceuticals, Inc.
Reg. No. 32069752759United States
Apellis Estonia OÜ
Reg. No. 14858554Estonia
Social engagement
Social engagement: 95.1K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
23 investors on record; lead investors include Hillhouse, VenBio, Solasta Ventures, Morningside; 3 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 16 | 70% |
| Private equity | 3 | 13% |
| Accelerator & incubator | 1 | 4% |
| Other / undisclosed | 3 | 13% |
Hiring activity
Hires periodically
11 roles tracked across 4 of the last 12 months
31 Mar 2026 · Territory Business Manager - Ophthalmology (San Antonio) · Minneapolis
12 Mar 2026 · Senior Director, Biostatistics · Waltham
27 Jan 2026 · Clinical Trial Manager · Waltham
21 Jan 2026 · Director, Compensation · Waltham
14 Jan 2026 · Care Educator (Midwest) · Minneapolis
Based on job postings tracked across public sources.
Recent activity
29 Jun 2026
Milestone
regulatory
14 May 2026
Milestone
anniversary
11 May 2026
Event
ARVO Annual Meeting 2026